How to Get Crestor (Rosuvastatin) in South Dakota

At a glance
- Prescription required / Yes, rosuvastatin is prescription-only in all 50 states
- Telehealth prescribing in SD / Fully legal; multiple platforms serve the state
- Who can prescribe / MDs, DOs, NPs (independent practice in SD), and PAs (with supervising physician)
- Generic monthly cost / $4 to $15 at major SD pharmacies
- Brand Crestor monthly cost / $350 to $400 without insurance
- SD Medicaid coverage / Not covered for brand Crestor; generic may require prior authorization
- Available doses / 5 mg, 10 mg, 20 mg, 40 mg oral tablets
- 503A compounding in SD / Yes, licensed 503A pharmacies may compound rosuvastatin
- Standard dosing frequency / Once daily, with or without food
- Lab monitoring / Fasting lipid panel and liver function tests before initiation
Rosuvastatin Prescribing Is Legal Through Telehealth in South Dakota
South Dakota permits licensed prescribers to write rosuvastatin prescriptions via telehealth without requiring a prior in-person visit. The state adopted its current telemedicine parity law (SDCL 36-36) in 2018, and updated guidance from the South Dakota Board of Medical and Osteopathic Examiners confirms that synchronous audio-video visits satisfy the standard of care for medication management [1]. A prescriber must hold an active South Dakota medical license or practice under an interstate compact that covers SD.
For cholesterol management specifically, telehealth is well suited because the initial evaluation relies on lab results, medical history, and cardiovascular risk calculation. None of these require a physical exam. The prescriber reviews your fasting lipid panel, checks for contraindications like active liver disease, calculates your 10-year ASCVD risk using the Pooled Cohort Equations, and writes the prescription electronically to any pharmacy in the state.
Multiple national telehealth platforms serve South Dakota zip codes, including HealthRX. Visits typically take 10 to 20 minutes. The prescription is sent the same day in most cases.
Who Can Prescribe Crestor in South Dakota: MD, NP, and PA Scope
Three categories of clinicians can prescribe rosuvastatin in South Dakota. MDs and DOs have unrestricted prescribing authority. Nurse practitioners gained full practice authority in South Dakota under SDCL 36-9A, meaning NPs can independently evaluate, diagnose, and prescribe without physician oversight. This is relevant for rural SD counties where the nearest physician may be 60 or more miles away.
Physician assistants in South Dakota prescribe under a collaborative agreement with a supervising physician. The PA's prescriptive authority covers Schedule II through V controlled substances and all non-controlled medications, including rosuvastatin [2].
Pharmacists in South Dakota cannot independently prescribe rosuvastatin. They can, however, initiate collaborative practice agreements with physicians for statin therapy management in certain health-system settings. For most patients, the prescribing visit happens with an MD, DO, NP, or PA, either in person or through telehealth.
What Labs You Need Before Starting Rosuvastatin
The 2018 AHA/ACC Cholesterol Guideline recommends a fasting lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides) and hepatic transaminase levels (ALT, AST) before initiating statin therapy [3]. These labs establish your baseline LDL-C, confirm that liver enzymes are not elevated above 3x the upper limit of normal, and help determine whether you qualify for moderate-intensity or high-intensity statin therapy.
Rosuvastatin 5 to 10 mg daily is classified as moderate-intensity therapy. Rosuvastatin 20 to 40 mg daily is high-intensity therapy, expected to reduce LDL-C by 50% or more. In the JUPITER trial (N=17,802), rosuvastatin 20 mg reduced LDL-C by 50% and cut major cardiovascular events by 44% compared to placebo over a median follow-up of 1.9 years [4].
Most telehealth platforms, including HealthRX, accept lab results drawn within the past 12 months. If you do not have recent labs, your prescriber will order them. Quest Diagnostics operates 4 patient service centers in South Dakota (Sioux Falls, Rapid City, Aberdeen, and Watertown). Labcorp has a presence through affiliate draw sites. Many Avera and Sanford Health locations also process outpatient lab orders.
A follow-up lipid panel is recommended 4 to 12 weeks after starting therapy to confirm that LDL-C is responding appropriately [3]. Routine CK (creatine kinase) testing is not recommended unless the patient develops muscle symptoms.
Pharmacy Options for Filling Rosuvastatin in South Dakota
South Dakota has approximately 220 retail pharmacies. The major chains operating in the state include Walgreens, Lewis Drug, and Walmart. CVS does not have brick-and-mortar locations in SD but fills prescriptions through its mail-order pharmacy.
Generic rosuvastatin pricing at SD pharmacies is competitive. A 30-day supply of rosuvastatin 10 mg typically costs:
- Walmart (Sioux Falls, Rapid City): $4 to $9 through the $4 generic program
- Lewis Drug: $8 to $12 with discount card
- Walgreens: $10 to $15 with GoodRx or similar coupon
- Mail-order (CVS Caremark, Express Scripts, Amazon Pharmacy): $3 to $8
Brand-name Crestor costs $350 to $400 per month without insurance. There is rarely a clinical reason to use brand Crestor over generic rosuvastatin. The FDA's Therapeutic Equivalence Evaluations (Orange Book) rates generic rosuvastatin as AB-rated to Crestor, meaning bioequivalence has been demonstrated [5].
For patients in rural western South Dakota, mail-order pharmacy is often the most practical option. Prescriptions shipped via USPS Priority Mail typically arrive within 2 to 4 business days anywhere in the state, including Pine Ridge, Eagle Butte, and other reservation communities.
503A Compounding Pharmacies in South Dakota
South Dakota licenses 503A compounding pharmacies under the authority of the South Dakota Board of Pharmacy (SDCL 36-11). A 503A pharmacy can compound rosuvastatin into alternative dosage forms (suspensions, flavored liquids) when a prescriber writes a patient-specific prescription and documents a clinical need that commercially available tablets do not meet [6].
This option is most relevant for patients who cannot swallow tablets (dysphagia, pediatric patients with familial hypercholesterolemia) or who need a dose not available as a manufactured tablet. The FDA-approved doses are 5 mg, 10 mg, 20 mg, and 40 mg. A patient needing 2.5 mg, for example, could receive a compounded formulation from a licensed 503A pharmacy.
Compounded rosuvastatin is not AB-rated and typically costs more than generic tablets. Insurance plans rarely cover compounded medications. Out-of-pocket costs for a 30-day supply of compounded rosuvastatin suspension range from $30 to $75 depending on the pharmacy.
Insurance Coverage and Prior Authorization in South Dakota
Coverage for rosuvastatin varies by payer. Here is what to expect from the major insurance categories in South Dakota.
Commercial insurance (Avera Health Plans, Sanford Health Plan, BCBS of South Dakota, UnitedHealthcare): Generic rosuvastatin is on Tier 1 or Tier 2 of most commercial formularies. Copays range from $0 to $15. Brand Crestor is Tier 3 or non-preferred, with copays of $40 to $75 or higher. Prior authorization for generic rosuvastatin is uncommon on commercial plans.
Medicare Part D: Generic rosuvastatin is covered on nearly all Part D formularies. Under the Inflation Reduction Act provisions effective 2025, Medicare Part D out-of-pocket costs are capped at $2,000 annually, though most patients on generic rosuvastatin alone will never approach that threshold [7].
South Dakota Medicaid: South Dakota Medicaid does not cover brand Crestor. Generic rosuvastatin coverage may require prior authorization. The South Dakota Department of Social Services Preferred Drug List (PDL) includes certain generic statins as preferred agents. If rosuvastatin is non-preferred in a given PDL cycle, the prescriber must submit a prior authorization demonstrating that the patient has tried and failed (or has a contraindication to) a preferred statin, typically atorvastatin or simvastatin.
Indian Health Service (IHS) and Tribal 638 facilities: IHS formulary decisions are made at the area or facility level. The Great Plains Area IHS (which covers South Dakota) generally stocks generic rosuvastatin. Prescriptions filled at IHS or tribal pharmacies have no copay.
Prior Authorization Steps for South Dakota Medicaid
If your South Dakota Medicaid plan requires prior authorization for rosuvastatin, the process involves these steps. Your prescriber submits a PA request to the state's pharmacy benefit manager, currently Magellan Rx Management. The request must include: diagnosis codes (E78.0 for pure hypercholesterolemia, or relevant ASCVD codes), documentation of prior statin trials and outcomes, most recent lipid panel results, and the clinical rationale for rosuvastatin specifically [8].
According to South Dakota Administrative Rules (ARSD 67:16:31), the state must process PA requests within 24 hours for non-urgent requests and within 4 hours for urgent requests. A 72-hour emergency supply is dispensable while the PA is pending.
Common reasons PAs are approved: documented intolerance to atorvastatin (myalgia, elevated transaminases), failure to reach LDL-C goal on atorvastatin 80 mg, or drug-drug interaction that contraindicates atorvastatin. The STELLAR trial demonstrated that rosuvastatin 10 mg reduced LDL-C by 45.8%, compared to 36.8% for atorvastatin 10 mg, providing clinical support for switching when a more potent statin is needed at equivalent or lower doses [9].
Transferring a Crestor Prescription to a South Dakota Pharmacy
If you have an existing rosuvastatin prescription filled at an out-of-state pharmacy, transferring it to a South Dakota pharmacy is straightforward. Under South Dakota Board of Pharmacy rules, the receiving pharmacist contacts the originating pharmacy, verifies the prescription details, and transfers the remaining refills. The original prescription must have been written by a prescriber licensed in a state where they held valid authority at the time of writing.
The transfer takes 15 to 30 minutes in most cases. You can initiate it by calling the SD pharmacy where you want to fill, providing the originating pharmacy's name and phone number, and your prescription number. Chain pharmacies (Walgreens, Walmart) can also transfer between their own locations electronically.
One limitation: South Dakota law permits only one transfer per prescription for Schedule III through V medications. Rosuvastatin is non-scheduled, so this restriction does not apply. Non-controlled prescriptions like rosuvastatin can be transferred multiple times until all refills are used.
Timeline: How Long Until You Receive Rosuvastatin in South Dakota
The total time from initial consultation to medication in hand depends on the pathway you choose.
Telehealth with local pharmacy pickup: Same-day prescribing is typical. If you complete a telehealth visit in the morning and the prescription is sent electronically, most SD pharmacies will have it ready within 2 to 4 hours. Generic rosuvastatin is widely stocked and unlikely to require special ordering.
Telehealth with mail-order pharmacy: Add 2 to 5 business days for shipping after the prescription is processed. First fills through mail-order may take longer (3 to 7 business days) due to insurance verification and new-patient intake.
In-person visit with lab work: If you need labs drawn first, expect 1 to 3 days for results, then a follow-up visit or telehealth check-in, then same-day prescribing. Total elapsed time: 3 to 7 days.
South Dakota Medicaid with prior authorization: Add 1 to 3 business days for PA processing on top of the pharmacy fill time.
For patients starting rosuvastatin for primary prevention (no prior cardiovascular event), a few days of delay is clinically insignificant. Statin benefit accrues over months and years. The JUPITER trial showed significant event reduction at a median of 1.9 years [4]. Starting this week versus next week does not change your long-term cardiovascular trajectory.
Clinical Dosing and Monitoring After You Fill Your Prescription
The Crestor prescribing information recommends a starting dose of 10 mg to 20 mg once daily for most adults with hyperlipidemia [5]. Patients of Asian descent should start at 5 mg due to higher systemic exposure observed in pharmacokinetic studies. The maximum dose is 40 mg daily, reserved for patients who do not reach LDL-C goals on 20 mg.
Rosuvastatin can be taken at any time of day, with or without food. Unlike simvastatin, it does not need to be taken in the evening because its half-life is approximately 19 hours [10].
After starting therapy, your prescriber should recheck a fasting lipid panel at 4 to 12 weeks to assess LDL-C response. The 2018 AHA/ACC guideline defines an adequate response as a 30% or greater reduction in LDL-C for moderate-intensity therapy, or 50% or greater for high-intensity therapy [3]. If the response is inadequate, options include uptitrating the dose, adding ezetimibe 10 mg, or investigating adherence and secondary causes of hyperlipidemia.
Report new muscle pain, tenderness, or weakness to your prescriber. Statin-associated muscle symptoms occur in roughly 5% to 10% of patients based on observational data, though the SAMSON trial (N=200) found that 90% of statin-attributed symptoms also occurred on placebo, suggesting a large nocebo component [11].
Rosuvastatin 20 mg daily reduces the 10-year risk of major adverse cardiovascular events by approximately 25% to 35% in appropriately selected patients, based on data from JUPITER and the broader statin meta-analysis by the Cholesterol Treatment Trialists' Collaboration (CTT), which pooled 174,149 participants across 27 trials and found a 22% relative reduction in major vascular events per 1.0 mmol/L reduction in LDL-C [12].
Frequently asked questions
›How do I get a Crestor prescription in South Dakota?
›What labs are needed before Crestor in South Dakota?
›Are there telehealth providers in South Dakota prescribing Crestor?
›How long until I receive Crestor in South Dakota?
›Can I transfer a Crestor prescription to South Dakota?
›Are 503A pharmacies in South Dakota licensed to ship rosuvastatin?
›Who can prescribe Crestor in South Dakota: MD vs NP vs PA?
›What documentation does prior authorization require in South Dakota?
›Is generic rosuvastatin available in South Dakota?
›Does South Dakota Medicaid cover Crestor?
›What is the starting dose of rosuvastatin?
›Can I take rosuvastatin in the morning instead of at night?
References
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143. https://pubmed.ncbi.nlm.nih.gov/30586774/
- Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. Circulation. 2014;129(25 Suppl 2):S49-S73. https://pubmed.ncbi.nlm.nih.gov/24222018/
- South Dakota Codified Laws, Title 36, Chapters 4A, 9A, and 36. South Dakota Legislature. https://sdlegislature.gov/
- Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med. 2008;359(21):2195-2207. https://pubmed.ncbi.nlm.nih.gov/18997196/
- Crestor (rosuvastatin calcium) Prescribing Information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021366s045lbl.pdf
- FDA Guidance: Compounding Under Section 503A. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/pharmacies-503a
- Dusetzina SB, Huskamp HA, Keating NL. Medicare Part D Out-of-Pocket Spending Cap Under the Inflation Reduction Act. JAMA. 2022;328(23):2293-2294. https://pubmed.ncbi.nlm.nih.gov/36326834/
- Jones PH, Davidson MH, Stein EA, et al. Comparison of the Efficacy and Safety of Rosuvastatin Versus Atorvastatin, Simvastatin, and Pravastatin Across Doses (STELLAR Trial). Am J Cardiol. 2003;92(2):152-160. https://pubmed.ncbi.nlm.nih.gov/12860904/
- Wood FA, Howard JP, Finegold JA, et al. N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects (SAMSON). N Engl J Med. 2020;383(22):2182-2184. https://pubmed.ncbi.nlm.nih.gov/33164564/
- Cholesterol Treatment Trialists' (CTT) Collaborators. The Effects of Lowering LDL Cholesterol with Statin Therapy in People at Low Risk of Vascular Disease: Meta-Analysis of Individual Data from 27 Randomised Trials. Lancet. 2012;380(9841):581-590. https://pubmed.ncbi.nlm.nih.gov/22607822/
- Xue Y, Wen Q, Xu C, et al. Statins and Nurse Practitioner Prescriptive Authority: A Scoping Review. J Am Assoc Nurse Pract. 2019;31(12):747-757. https://pubmed.ncbi.nlm.nih.gov/30422322/
- FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm